LightUp gets Boston Probes' PNA technology:
This article was originally published in Clinica
Development company Boston Probes has granted a non-exclusive licence to LightUp Technologies for its PNA technology for infectious disease diagnostic applications. PNA is a synthetic probe with enhanced functional properties compared with nucleic acid probes, the companies say. Goteborg, Sweden-based LightUp will pay an undisclosed, up-front fee, a milestone payment and royalties from product sales. Boston Probes, of Bedford, Massachusetts, will also get an equity position in LightUp.